December 11th 2024
Study shows sildenafil cream 3.6% improves sexual arousal in diverse women with FSAD, offering hope for millions seeking effective treatment.
The Sexual Health and Wellness Consortium features a variety of informative videos, articles, podcasts, polls, and quizzes to help you better care for your patients as they navigate their sexual health and wellness journey.
Patient, Provider, and Caregiver Connection™: Exploring Unmet Needs In Postpartum Depression – Making the Case for Early Detection and Novel Treatments
View More
Identifying Health Care Inequities in Screening, Diagnosis, and Trial Access for Breast Cancer Care: Taking Action With Evidence-Based Solutions
View More
16th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™
May 3, 2025
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Burst CME™: The Patient Journey – Unmet Needs From Diagnosis Through Management of Migraine
View More
Burst CME™: Optimizing Migraine Management – Addressing Unmet Needs, Individualizing Care for Diverse Populations, and Utilizing CGRP Targeted Agents
View More
Burst CME™: Optimizing the Use of CGRP Targeted Agents for the Treatment of Migraine
View More
Burst CME™: Setting the Stage – Individualizing Migraine Care for Diverse Populations Across Care Settings
View More
‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis
View More
Navigating Low-Grade Serous Ovarian Cancer – Enhancing Diagnosis, Sequencing Therapy, and Contextualizing Novel Advances
View More
Burst CME™: Implementing Appropriate Recognition and Diagnosis of Low-Grade Serous Ovarian Cancer
View More
Burst CME™: Stratifying Therapy Sequencing for LGSOC and Evaluating the Unmet Needs of the Standard of Care
View More
Burst CME™: Understanding Novel Advances in LGSOC—A Focus on New Mechanisms of Action and Clinical Trials
View More
Cases and Conversations™: Navigating the Complexities of Managing Myasthenia Gravis in Pediatric and Pregnant Patient Populations
View More
Subjective and Objective Outcomes of Botulinum Toxin Type A Treatment in Vestibulodynia
Botulinum toxin type A may be effective in reducing coital pain in vestibulodynia with levator ani tenderness, but has little effect on vestibular allodynia.
Read More
The Treatment of Dyspareunia Resulting from Vulvar Vestibulitis
A Randomized Comparison of Group Cognitive-behavioral Therapy, Surface Electromyographic Biofeedback, andVestibulectomy in the Treatment of Dyspareunia Resulting from Vulvar Vestibulitis
Read More
Clinical Management of Vulvodynia
October 24th 2011Vulvodynia, also known as burning vulva syndrome, is characterised by sensory abnormalities of the vulva and the surrounding tissue, such as an unpleasant burning and itching sensation, or a painful response to a stimulus that is not usually painful such as sexual intercourse or the touch of a cotton swab.
Read More
Chronic Pelvic Pain: Which Approach? Surgical Versus Medical
October 24th 2011Chronic pelvic pain is generally used to describe a condition of pelvic discomfort not solely associated with menstruation, of more than 6 month's duration, and of a severity sufficient to cause disability in some form.
Read More
Painful Intercourse After Delivery
October 24th 2011A 26 year-old woman delivered her first baby, weighing 7 pounds, 6 ounces, without difficulty after 35 minutes of pushing. Although her doctor used perineal stretching (gentle stretching of the area between the vagina and anus) and lubricants during delivery, there was a small, second-degree tear of the vagina and perineum as the baby's shoulders delivered.
Read More
Infertility is a disease that affects the reproductive organs of both men and women. It impairs one of the body’s most basic functions: the ability to have children. Infertility affects about 6.1 million people in the United States alone; ten percent of the reproductive-age population-both men and women.
Read More
A cost efficient approach to the diagnosis and treatment of infertility for the OBGYN generalist
October 8th 2011The purpose of this proposal is to outline suggested clinical pathways for the management of infertility and common reproductive endocrinology problems. The goal is to create an approach that provides the greatest success while using limited resources in the most cost-effective fashion.
Read More
Rekindling Romance at Mid-Life
October 7th 2011All week, you would plan what to wear and think of how it was going to be. Your heart beat with excitement as you thought of what might happen that night... The day of the date arrived, you took special care with your hygiene. You placed perfume behind your knees, etc. made sure you wore your prettiest and cleanest lingerie, and you were ready.. So, was he, as he too planned for this special night. "Pleasurable Anticipation"
Read More
43% of American Women Are Sexually Dysfunctional? Hype or Reality?
October 7th 2011A study published in the Journal of the American Medical Association asserts that 43% of American women are experiencing some sort of sexual dysfunction during a 12 months period. As a result, female sexuality has become the new mass media debate. With all that exposure many women are wondering if something is wrong with them? What’s going on?
Read More
What Are "Designer Estrogens"?
October 7th 2011Designer estrogens, SERMS, are two terms currently being used to describe the actions of a medication that acts as an estrogen on one tissue and an anti-estrogen on others. The ideal estrogen medication would switch of or off the effects of estrogen at different sites in the woman's body.
Read More
Patients with endometriosis can have symptoms varying from constant excruciating pelvic pain to no symptoms whatsoever. Paradoxically, the extent of endometriosis has no correlation to the amount of pain a women will experience. Some women with severe endometriosis do not have any symptoms and may not know they have endometriosis until a pelvic mass is detected on a routine pelvic examination or a problem with infertility is discovered.
Read More
A fibroid is a benign tumor of the uterus. Various terms are used to refer to the tumor, such as fibromyoma, myofibroma, leiomyofibroma, fibroleiomyoma, myoma, fibroma, and fibroid. Of these, fibroid is the most common term, although myoma is more accurate.
Read More
Uterine prolapse or dropped womb is a condition in which the uterus drops downward in the pelvis below its normal position. The uterus may drop slightly and remain above the introitus (vaginal opening, grade 1). It may drop further so that the cervix or lower portion of the uterus reach the region of the introitus (grade 2). In the most severe form, the cervix or even the entire uterus bulges out of the introitus (grade 3). Uterine prolapse is the indication for hysterectomy in 16% of cases in the U.S.
Read More
The cervix is the part of the uterus connected to the upper vagina. It is the structure that dilates during childbirth to allow the baby to traverse the birth canal. There are two major types of cancer that develop from the cervix. Squamous cell cancers arise from the squamous epithelium that covers the visible part of the cervix. Adenocarcinomas arise from the glandular lining of the endocervical canal.
Read More
The Pap test is a screening test for malignant and premalignant changes of the cervix. A positive result indicates that there may be a problem and that further diagnostic procedures must be done. The Pap test is not a diagnostic test. It cannot be used to exclude a cancer of the cervix for a person who has symptoms that could be due to a cervical cancer.
Read More
The Papanicolaou (Pap) test is the best screening test we have in medicine. Countries that perform the test, like the USA, prevent over 90% of cervical cancers. Pap tests should not detect cervical cancer, because it is the cervical cancer we want prevent. Our goal is to detect pre-cancerous changes, and treat cases in their pre-cancerous state. Earlier findings require less costly and less painful treatment.
Read More
The National HPV & Cervical Cancer Campaign You Need to Know
September 26th 2011The National HPV & Cervical Cancer Campaign is a public education campaign whose goal is to reduce the number of preventable deaths each year by cervical cancer through increased education, outreach and communication between women and their health care providers.
Read More
STI Reinfection Rates Reduced by Expedited Partner Therapy
September 19th 2011When chlamydia or gonorrhea is diagnosed in female patients, obstetricians and gynecologists should also prescribe antibiotics for the male partners. This recommendation comes from The American College of Obstetricians and Gynecologists in efforts to reduce the high reinfection rates associated with these sexually transmitted infections (STIs).
Read More
Semi-Qualitative Study of Attitudes To Vaccinating Adolescents Against HPV Without Parental Consent
September 14th 2011The first vaccine to prevent human papillomavirus (HPV) and cervical cancer has been licensed, and in future, vaccination may be routinely offered to 10–14 year old girls. HPV is a sexually transmitted virus and some parents may refuse consent for vaccination.
Read More
Antenatal Care: Clinical Guideline
August 17th 2011• The following guidance is evidence based. • Developed by the National Collaborating Centre for Women's and Children's Health • Developed at October 2003, valid till 2007 • The grading scheme used for the recommendations (A, B, C, D, good practice point [GPP], and NICE 2002)
Read More